|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.61 CNY | +1.14% |
|
+0.22% | +5.62% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.14% | +0.22% | +25.74% | +2.31% | +5.62% | +8.26% | -32.69% | -35.32% | - | 3.09B | |
| +2.11% | +1.50% | +18.14% | -17.94% | -31.93% | -21.54% | -30.04% | -54.89% | - | 15.05B | |
| +1.91% | -1.05% | +5.01% | +9.36% | -7.61% | -20.96% | -7.90% | +49.43% | +214.17% | 5.91B | |
| +1.65% | +6.29% | +21.78% | -8.09% | +1.93% | -9.41% | -30.12% | -24.46% | +90.00% | 3.9B | |
| +0.22% | +3.15% | -0.90% | -10.30% | -1.89% | -28.64% | -46.86% | - | - | 3.22B | |
| +0.71% | -7.44% | -3.95% | -20.18% | -36.93% | -41.90% | -23.89% | -18.51% | +66.49% | 2.96B | |
| +1.72% | +3.47% | +5.24% | -3.80% | -13.11% | -13.21% | +3.25% | +43.11% | +118.85% | 2.63B | |
| +3.34% | +3.95% | +2.25% | +9.02% | +37.42% | +99.37% | - | - | - | 2.56B | |
| +1.36% | -1.90% | -1.83% | +36.47% | +2.84% | -36.78% | -36.24% | -48.14% | - | 1.51B | |
| -0.67% | -7.92% | -11.47% | -18.77% | -15.29% | -4.51% | +21.07% | -7.05% | - | 1.51B | |
| +2.70% | +0.53% | -1.55% | +10.79% | +33.37% | +52.92% | +107.97% | +220.40% | +314.30% | 1.14B | |
| -0.03% | -.--% | -.--% | -.--% | -.--% | -.--% | -.--% | -7.44% | +2.26% | 1.14B | |
| +3.47% | +0.09% | +14.68% | -9.65% | -11.90% | -24.57% | -55.39% | -62.79% | -55.48% | 928M | |
| -0.05% | -0.54% | -6.45% | -17.85% | -18.68% | -46.68% | -61.35% | - | - | 919M | |
| -0.51% | -10.51% | -14.14% | -20.67% | -11.20% | -20.01% | -23.35% | - | - | 899M | |
| +1.11% | -3.88% | -1.62% | +11.77% | -20.73% | -37.57% | - | - | - | 776M | |
| +5.81% | -4.88% | -2.33% | -30.10% | -25.43% | -5.79% | -24.37% | - | - | 773M | |
| +3.74% | +1.96% | -4.66% | -12.17% | -15.32% | -3.70% | -35.32% | -39.13% | - | 721M | |
| +3.97% | +4.24% | +18.73% | +1.55% | -20.77% | -4.84% | +54.72% | +84.51% | - | 705M | |
| -0.39% | -3.01% | +17.41% | +47.43% | +73.45% | +26.39% | -80.06% | -96.99% | - | 620M | |
| Average | +1.68% | -1.75% | +4.00% | -2.04% | -3.81% | -6.66% | -16.70% | +0.20% | +107.23% | 2.55B | |
| Weighted average by Cap. | +1.69% | -1.14% | +9.08% | -6.20% | -11.56% | -11.07% | -21.29% | -14.52% | +130.91% |
- Stock Market
- Stocks
- 603233 Stock
- Sector DaShenLin Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
